ARIAD Pharmaceuticals, Inc. (aria) Stock Ratings


View Stock Quote:

aria

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


Bullish

100% of 1 ratings

View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks
Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
The Rig Master 05/13/2013 3 months $17.17 $17.17 no change 0 Active
Comments: today's real price should be $30. Possible take over.
JOKER66 04/04/2013 1 day $16.76 $16.88 +0.72% 1 Ended
Comments:
john70 05/21/2012 3 months $15.98 $19.75 +23.59% 23 Ended
Comments: Industry sector growing or poised for growth
AbelFont 05/02/2012 1 Year $16.59 $15.41 -7.11% -7 Ended
Comments: Industry sector growing or poised for growth
andy_62 02/06/2012 3 months $15.89 $16.15 +1.64% 1 Ended
Comments: Upcoming product launch will be successful
texan_1 08/23/2011 3 months $8.51 $18.24 +114.31% 114 Ended
Comments: Projecting strong long-term growth
sync_1 07/25/2011 1 Year $13.00 $18.24 +40.31% 40 Ended
Comments: Industry sector growing or poised for growth
leah_4 04/26/2011 3 months $8.19 $18.24 +122.71% 122 Ended
Comments: This stock is undervalued
Salah Younis 04/25/2011 1 month $8.14 $18.24 +124.08% 124 Ended
Comments: This stock is undervalued
Tal Chesler 05/11/2010 3 months N/A Ended
Comments: ,TOO GOOD.
capcomtrader 04/20/2010 3 months N/A Ended
Comments:
mitware 03/27/2010 3 months N/A Ended
Comments:
bobb_2 03/10/2010 3 months N/A Ended
Comments:
bth54 12/09/2009 3 months N/A Ended
Comments: a lot of positive work in the pipeline.

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.